San Francisco, San Mateo Co. Residents Urged to Share Long COVID Stories

UCSF, San Francisco Department of Public Health (SFDPH) and San Mateo County Health (SMC Health) are partnering with local community groups to learn about long COVID. Their project, Let’s Figure Out Long COVID – Tell Us Your Story, Bay Area, will call local residents of all ethnicities and...

People in Shelter-in-Place Hotels Used Less Acute Health Services

San Francisco’s pandemic policy of offering hotel rooms, meals, and medical services to unhoused populations saw the unintended benefit of dramatically lowering the use of emergency medical services.

Overcrowding, Old Buildings Fueled COVID Surge in California Prisons

Overcrowding, antiquated buildings, rapidly changing conditions and the need for complex coordination helped drive a dramatic COVID-19 surge in California’s prisons, according to a new report from UCSF and UC Berkeley.

COVID-19 Vaccines for Children Under 5: UCSF Explains What You Should Know

Parents of children under the age of five-years-old now have the option to vaccinate their infants and young children against COVID-19. Our expert looks at potential vaccine side effects, risks of COVID-19, access and vaccine effectiveness in children.

In Long COVID, Blood Markers Are Linked to Neuropsychiatric Ills

In a new study of long COVID, UCSF researchers identified biomarkers present at elevated levels that may persist for many months in the blood of study participants who had long COVID with neuropsychiatric symptoms.

Navigating From the Genome to the Clinic Using ‘Cell Maps’

Nevan Krogan, PhD, director of UCSF’s Quantitative Biosciences Institute, examines in detail the effects of a handful of genes that seem to play an outsize role in a wide array of diseases.

UCSF Awarded $67.5 Million to Develop New Antiviral Therapies

Scientists at UCSF QBI and the QBI Coronavirus Research Group (QCRG) have been awarded $67.5 million from the National Institute of Allergy and Infectious Diseases (NIAID) to support its mission of pandemic preparedness.

COVID Drug May Also Ease Symptoms of Long COVID

An antiviral drug approved for high-risk COVID patients may also benefit those with long COVID, according to the findings of a small case series that need to be confirmed with future rigorous studies.

Your Mental Health May Impact Your Chances of Breakthrough COVID

A new UCSF-led study showed that people who are vaccinated against COVID-19, and have a history of certain psychiatric conditions, have a heightened risk of infection – a finding that may be related to impaired immune response.

UCSF Deploys Innovative Data System to Integrate Research and Care

UCSF, in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the U.S. Food and Drug Administration (FDA), has developed the OneSource system to seamlessly integrate clinical care and research data.